Discontinuation report GEMCITABINE FOR INJECTION, USP

Last updated on 2017-04-13 History
Report ID 6701
Drug Identification Number 02407310
Brand name GEMCITABINE FOR INJECTION, USP
Common or Proper name Gemcitabine
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GEMCITABINE
Strength(s) 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 1
ATC code L01BC
ATC description ANTIMETABOLITES
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-04-12
Remaining supply date 2017-04-10
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-04-13 French Compare
v1 2017-04-13 English Compare

Showing 1 to 2 of 2